A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Conditions
- Pancreatic Cancer, Metastatic
- PDAC - Pancreatic Ductal Adenocarcinoma
Interventions
- DRUG: E-EDV-D682
- DRUG: EDV-GC
- DRUG: Gemcitabine
- DRUG: Nab paclitaxel.
Sponsor
Engeneic Pty Limited
Collaborators